Virtual reality sheds light on breathlessness in COPD

NCT ID NCT07568379

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares how COPD patients and healthy individuals experience breathlessness at rest, during exercise, and in virtual reality. Researchers will also test whether a placebo (high-flow nasal cannula) can change how breathlessness feels. The goal is to better understand the brain and body mechanisms behind this distressing symptom.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could improve our understanding of breathlessness in COPD, potentially leading to better ways to measure and manage it.

What could go wrong

This is a small, early-stage lab study, not a treatment trial. Results may not apply to real-world settings or lead directly to new therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset Dyspnea Respiratory Aspiration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Univesity of Deusto

    San Sebastián, 20012, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••